We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Whole Blood-plasma-oral Fluid Ratios of Psychoactive Drugs and Medicines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00650130
Recruitment Status : Completed
First Posted : April 1, 2008
Last Update Posted : November 4, 2013
Information provided by (Responsible Party):

Study Description
Brief Summary:

The aim of this study is to get new information on the whole blood-plasma-oral fluid ratios of psychoactive drugs which are encountered in traffic.

Samples are taken from drivers suspected of being under the influence of drugs or medicines. The samples are analysed with immunological methods and GC-MS.

Observations from Police and a physician on impairment are combined with the results of the different bodily fluids. Observational evaluations and substance concentrations are compared.

Condition or disease
Driving Under the Influence

Study Design

Study Type : Observational
Actual Enrollment : 300 participants
Observational Model: Case Control
Official Title: DRUID Sub-study: Substance Concentration Ratio/Impairment
Study Start Date : May 2008
Primary Completion Date : December 2008
Study Completion Date : October 2011
Groups and Cohorts

drivers of motorised vehicles suspected of being under the influence of psychoactive drugs

Outcome Measures

Primary Outcome Measures :
  1. ratio of psychoactive drugs/medicines in whole blood-plasma-saliva and correlation to symptoms of impairment [ Time Frame: 1 year ]

Secondary Outcome Measures :
  1. prevalence of psychoactive substances in the general driving population [ Time Frame: three years ]

Biospecimen Retention:   Samples With DNA
Blood samples and oral fluid are collected for the study. However no DNA detection is done at any stage. The laboratory where samples are analysed do not analyse DNA. DNA is not relevant to this study.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
drivers of motorised vehicles in general road traffic

Inclusion Criteria:

  • 18 years or older
  • driver of a motorised vehicle

Exclusion Criteria:

  • 17 years or younger
  • not the driver of a motorised vehicle
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00650130

National Public Health Institute
Helsinki, Finland
Sponsors and Collaborators
National Institute for Health and Welfare, Finland
Helsinki University
Ministry of Internal Affairs, Finland
European Commission
Principal Investigator: Pirjo Lillsunde, Dr National Public Health Institute, Helsinki, Finland
More Information

Additional Information:
Responsible Party: National Institute for Health and Welfare, Finland
ClinicalTrials.gov Identifier: NCT00650130     History of Changes
Other Study ID Numbers: KTL 417-7
First Posted: April 1, 2008    Key Record Dates
Last Update Posted: November 4, 2013
Last Verified: November 2013

Keywords provided by National Institute for Health and Welfare, Finland:
driving under the influence
psychoactive substances
oral fluid
whole blood
Ratio of psychoactive substances in whole blood-plasma-oral fluid
Prevalence of psychoactive substances in road traffic

Additional relevant MeSH terms:
Psychotropic Drugs